If you searched for resveratrol bioavailability, you are probably staring at a shelf where one bottle says trans-resveratrol 500 mg from Japanese knotweed, another says liposomal at a fifth of the dose for triple the price, and a third bottle is selling pterostilbene as the "next-generation" version, and you want to know which one actually reaches your bloodstream.
Before you decide
Who should NOT pick a form by price alone: anyone on warfarin or another anticoagulant, anyone on a CYP3A4-sensitive medication such as cyclosporine or several statins, anyone with a hormone-sensitive cancer history or on tamoxifen, and anyone post-menopause considering high-dose hormone-modulating protocols.
Do this first before buying anything: confirm with the prescribing clinician that none of your current medications sit on the interaction list below. Resveratrol is a polyphenol with real pharmacology, not a vitamin.
What bioavailability means for resveratrol
Resveratrol is a stilbene polyphenol produced by grapes, Japanese knotweed, and a handful of other plants as a defense compound. The molecule has two stereoisomers. Trans-resveratrol is the biologically active form that almost every published trial uses. Cis-resveratrol is less stable and weaker mechanistically, and in commercial supplements it usually appears as a low-percentage impurity rather than a main ingredient. A high-quality label that says "standardized to 98% trans-resveratrol" leaves the remaining 2% as mostly cis plus minor knotweed phenolics, which is normal.
The absorption problem defines the entire category. After an oral dose, trans-resveratrol crosses the small intestine reasonably well, with fractional absorption around 70%, which sounds excellent. The catch is what happens next. The molecule is rapidly conjugated by Phase II enzymes in the intestinal wall and the liver into resveratrol glucuronides and resveratrol sulfates, and the parent compound barely makes it into systemic circulation. The Walle et al. 2004 human bioavailability paper reports that free trans-resveratrol bioavailability is below 1% after a 25 mg dose, with the bulk of the dose circulating as conjugated metabolites.
The proxy metrics used in trials are imperfect. Plasma total resveratrol (free aglycone plus conjugates) measured after enzymatic deconjugation is the standard endpoint, alongside area under the curve and Cmax. Tissue and intracellular concentrations are almost never measured in human studies. Think of it like judging how much of a delivery actually reached the kitchen by counting what is left on the porch.
The forms compared
Trans-resveratrol from Japanese knotweed
Almost all commercial resveratrol is extracted from Polygonum cuspidatum, the plant Western herbalism calls Japanese knotweed and TCM calls Hu Zhang, where the root has a long history of use for inflammation and circulation. Knotweed root is roughly 20 times more concentrated in resveratrol than grape skin, so the extraction economics favor it. Quality grades range from 50% trans-resveratrol up to standardized 98% or higher. Lower-percentage extracts carry more of the other knotweed phenolics, which some naturopathic practitioners argue is a feature rather than a defect. The mainstream supplement market has standardized on the high-purity 98% trans form at 250 to 500 mg per capsule.
Cis-resveratrol
Cis-resveratrol is the photo-isomerized form. Light exposure during processing converts a fraction of trans to cis, which is why high-quality manufacturers store and ship raw material under amber glass and low-light conditions. The cis form is less stable, has weaker SIRT1 activity in cell models, and is not the form any of the published clinical trials standardized on. You do not buy cis-resveratrol on purpose. You verify your trans-resveratrol product has minimal cis content, ideally documented on the certificate of analysis.
Liposomal resveratrol
Liposomal resveratrol encapsulates trans-resveratrol inside phospholipid bilayers built around phosphatidylcholine, with the goal of protecting the molecule from gut and hepatic conjugation long enough to raise plasma exposure. Brands in this space claim 5 to 15 times higher bioavailability than standard powder-filled capsules. Some replicated absorption data supports a meaningful increase, though most of what is published is industry-sponsored. Treat the liposomal claim as plausible and probably real at the lower end of the marketing range, but not yet sitting on the same evidence footing as a patented phytosome with multiple independent crossover trials. The format usually delivers 100 to 200 mg per dose in a liquid or softgel.
Resveratrol plus piperine
Piperine, the black pepper alkaloid, inhibits intestinal P-glycoprotein and slows the same Phase II conjugation enzymes that destroy curcumin and resveratrol in the gut wall and liver. The mechanism is well established. Pairing 5 to 10 mg of piperine with a standard 500 mg trans-resveratrol dose meaningfully raises plasma exposure in absorption studies. It is a reasonable budget alternative to a true delivery-system product, though piperine pulls double duty for other co-ingested drugs and supplements in ways readers on multiple medications should account for.
Resveratrol plus quercetin
The resveratrol-plus-quercetin combination is built on the observation that quercetin competes for the same Phase II conjugation enzymes that strip resveratrol, leaving more parent compound briefly available. The synergy claim has thin direct human data. The combination is defensible because both molecules earn separate places in a polyphenol-supportive stack, but treat the absorption claim as mechanistically plausible rather than RCT-confirmed.
Pterostilbene
Pterostilbene is 3,5-dimethoxyresveratrol, the natural methylated analog produced in blueberries and a few other plants. The two methoxy groups protect the molecule from glucuronidation, which is the entire mechanism that wrecks resveratrol bioavailability. Oral absorption is roughly 4 to 7 times higher per milligram than trans-resveratrol on equimolar comparisons in the published rodent and small human work, and the plasma half-life is meaningfully longer (about 105 minutes versus roughly 14 minutes for resveratrol). The Riche 2014 cardiovascular trial used 125 mg twice daily and is the cleanest endpoint trial in this part of the literature.
| Form | Relative bioavailability vs trans-resveratrol | Typical dose | Cost per dose (mid-tier US) | Notes |
|---|---|---|---|---|
| Trans-resveratrol (standard) | 1.0x (reference) | 250 to 1000 mg | $0.20 to $0.40 | Cheap, abundant, the form used in most trials |
| Cis-resveratrol | <1.0x and less stable | n/a | n/a | Impurity, not a target ingredient |
| Liposomal resveratrol | ~5x to 15x claimed, ~3x to 5x is defensible | 100 to 200 mg | $0.50 to $1.20 | Independent data thinner than marketing implies |
| Resveratrol plus piperine | ~2x to 4x | 500 mg plus 5 to 10 mg piperine | $0.25 to $0.45 | Watch for piperine drug-interaction effects |
| Resveratrol plus quercetin | ~1.5x to 2x (extrapolated) | 500 mg plus 250 to 500 mg quercetin | $0.40 to $0.70 | Mechanism plausible, direct human data limited |
| Pterostilbene | ~4x to 7x oral exposure, longer half-life | 100 to 200 mg | $0.40 to $0.60 | Different molecule, cleanest cardiometabolic dataset |
The RCT evidence per form
Direct head-to-head bioavailability trials between resveratrol forms in humans are smaller and fewer than the supplement industry implies, and the clinical-endpoint trials almost all use trans-resveratrol at doses ranging from 75 mg to 5 grams per day. Human translation of the cell-culture and rodent longevity findings has been mixed, and most of the "longevity" marketing for this category rests on mechanism rather than hard outcome data.
The Walle 2004 work is where the sub-1% free-compound figure comes from. The Boocock et al. 2007 dose-escalation study gave healthy volunteers single doses from 500 mg up to 5 grams, found absorption stayed reasonable but plasma free resveratrol stayed low, and reported mild gastrointestinal symptoms at the higher doses. That study is the reason experienced formulators do not push standard resveratrol above 1000 to 1500 mg per day without a specific clinical reason.
On the clinical endpoint side, the Witte et al. 2014 cognitive trial gave 200 mg of trans-resveratrol per day for 26 weeks to 46 healthy older adults and reported improved memory performance and modest changes on functional MRI versus placebo. That 200 mg figure is the most quotable cognitive dose in the literature for this population. The Yoshino et al. 2012 trial gave 75 mg per day for 12 weeks to 29 non-obese postmenopausal women with normal glucose tolerance and reported no improvement in insulin sensitivity, which is one of the cleaner null trials in the dataset. The Movahed et al. 2013 trial gave 1 gram per day for 45 days to 66 adults with type 2 diabetes and reported a modest drop in fasting glucose, hemoglobin A1c, and systolic blood pressure versus placebo. The pterostilbene side is anchored by Riche 2014, which gave 125 mg twice daily to adults with elevated cardiovascular risk and reported reductions in blood pressure and total cholesterol.
Mechanistically, resveratrol activates the SIRT1 deacetylase and modulates AMPK signaling in cell and rodent models, which is the entire basis for the longevity story. Whether that mechanism translates to a clinical effect at the doses people actually take is a separate question, and the dose math is unforgiving. The SIRT1 activation seen in rodent studies often required roughly 50 mg per kilogram of body weight, which scales to about 3500 mg for a 70 kg adult. Consumer doses of 250 to 500 mg are seven to fourteen times below that level. Pterostilbene's better absorption and longer half-life close part of that gap on an equimolar basis, which is the strongest single argument in favor of it over standard resveratrol for general longevity-curious supplementation.
Actionable takeaway: the trial data supports cognitive benefit at the modest 200 mg trans-resveratrol dose in older adults, cardiometabolic benefit at the gram-level dose in diabetics, and cardiovascular benefit at the 250 mg total pterostilbene dose in elevated-risk adults. Anything below 200 mg of resveratrol or 100 mg of pterostilbene is below the relevant trial dose, regardless of how the marketing frames it.
Cost-vs-bioavailability decision matrix
Here is the honest math. A 500 mg trans-resveratrol dose at $0.30 works out to about $0.0006 per milligram of resveratrol on the label. A 150 mg pterostilbene dose at $0.50 works out to about $0.0033 per milligram on the label. On a label-milligram basis the pterostilbene looks five to six times more expensive. On a plasma-exposure basis, factoring in the roughly 4x to 7x oral bioavailability and the longer half-life that keeps the molecule circulating, pterostilbene is delivering more usable stilbene per dollar than the standard form for the same general-longevity goal. A liposomal product at $1.00 per 200 mg dose lands at about $0.005 per milligram and earns its place when the goal is reliable plasma exposure of resveratrol specifically, such as inside a Sinclair-style NMN-and-resveratrol stack.
When does the premium form pay off? When the protocol is specifically anchored on resveratrol (NMN or NR stacking, the published 200 mg cognitive dose in an elderly reader with mild memory complaints, or a clinician-co-managed cardiometabolic program at the gram-level dose), and you want consistent absorption rather than gambling on first-pass metabolism. When is the cheap standard form fine? For the general longevity-curious adult who wants to experiment with stilbene supplementation without overpaying, especially when paired with a fatty meal. When is the multi-ingredient 25 mg "resveratrol blend" appropriate? Almost never for a therapeutic goal. It sits below the Witte cognitive dose by an order of magnitude.
And the wine. A standard 100 mL pour of red wine carries roughly 1 mg of resveratrol, so matching a single 250 mg capsule would require 250 glasses. The alcohol cost would arrive long before any meaningful resveratrol intake did. Wine has cultural and small-pleasure value. It is not a serious resveratrol delivery vehicle.
How to choose the right form for your goal
If your goal is general longevity-curious supplementation
Pterostilbene 100 to 200 mg per day with a fatty meal. Better absorption, longer half-life, cleaner cardiometabolic readout in the published trial, and an honest match for the stilbene-class mechanism without pretending the dose math for standard resveratrol works out. For the broader context on what else belongs in a longevity stack and where the strongest evidence actually sits, see the existing guide on the best supplements for longevity in 2026.
If you are following a specific Sinclair-style NMN plus resveratrol protocol
Trans-resveratrol 500 to 1000 mg per day with a fatty meal, ideally from a 98% standardized Japanese knotweed extract. This is the molecule the protocol references, and substituting pterostilbene at this stage means you are running a different experiment. Liposomal resveratrol at 200 to 400 mg is a reasonable substitution when pill burden or absorption reliability matters more than matching the protocol dose exactly.
If your goal is cognitive support in an older adult with mild memory complaints
Trans-resveratrol 200 mg per day for at least 6 months, matching the Witte 2014 dose and duration. If memory complaints are progressive or functional, the conversation is conventional neurology referral first, supplement support second.
If your goal is cardiometabolic support alongside lifestyle change
Liposomal trans-resveratrol 200 to 400 mg per day, or pterostilbene 125 mg twice daily per the Riche protocol. If your clinician is managing diagnosed diabetes or established cardiovascular disease, the supplement is an adjunct to the prescribed standard of care, not a replacement for it.
If you are pregnant or trying to conceive
Skip resveratrol and pterostilbene supplementation entirely. There is no adequate safety dataset for either molecule at supplemental doses in pregnancy, and resveratrol has phytoestrogen activity in cell models that has not been adequately characterized in humans. Dietary intake from grapes and blueberries is not a concern.
If you take warfarin, cyclosporine, tamoxifen, or another CYP3A4-sensitive medication
Talk to your prescribing clinician before starting any stilbene supplement. Per the Drugs.com resveratrol interaction monograph, resveratrol has additive antiplatelet activity with warfarin and other anticoagulants, inhibits CYP3A4 in a way that can raise levels of substrates including cyclosporine and several statins, and has estrogen-receptor modulating activity that creates uncertainty around tamoxifen and other hormone-targeted oncology drugs. These are not deal-breakers in every case, but they are real conversations to have with the prescriber before you add a polyphenol with this much pharmacology.
FAQ
Is liposomal resveratrol a scam or a real form? Liposomal resveratrol is a real delivery technology, and the underlying absorption logic is sound. The fair criticism is that the independent human bioavailability evidence is thinner than the marketing implies, and the typical 5x to 15x claim is at the optimistic end of what the published data supports. A 3x to 5x improvement is a more honest range to plan around.
Why does the pterostilbene label dose look so much smaller than a resveratrol label dose? Because the absorption per milligram is much higher and the half-life is longer. A 150 mg pterostilbene dose is targeting comparable usable stilbene exposure across the day to a roughly 1000 mg standard resveratrol dose. That is the entire premise of the molecule.
Can I take resveratrol with food? Yes, and for trans-resveratrol and liposomal forms a meal that contains some fat improves absorption modestly because both molecules are lipophilic. Pterostilbene is less food-dependent, but taking it with a meal is the simpler habit to keep. The exception is the drug-spacing question for any CYP3A4-sensitive medication, which is a clinician conversation rather than a meal-timing tweak.
Are practitioner-channel resveratrol brands worth the markup? Sometimes yes, when the brand documents the trans-resveratrol percentage on a third-party certificate of analysis, sources from a reputable Japanese knotweed supplier, and stores under amber glass and cool conditions. Often no, when the practitioner price reflects channel margin rather than ingredient quality. A USP-verified or NSF-certified retail brand using a 98% standardized extract is usually the better value, and ConsumerLab spot-checks of this category have found wide variation in actual trans-resveratrol content versus label claims.
Does drinking more red wine give me a meaningful resveratrol dose? No. A 100 mL glass of red wine carries roughly 1 mg of resveratrol, so matching a single 250 mg capsule would mean about 250 glasses. Wine has cultural and gastronomic value. It is not a viable resveratrol delivery vehicle, and the calorie and ethanol cost of pretending it is would land long before any meaningful intake did.
Conclusion: the bottom line on resveratrol bioavailability
For the typical longevity-curious adult, pterostilbene at 100 to 200 mg per day is the more honest pick on the basis of better oral absorption, a longer plasma half-life, and a cleaner published cardiometabolic trial at a realistic dose. Standard trans-resveratrol still earns its place when the protocol you are following specifically references the resveratrol molecule (the Sinclair-style NMN stack, the Witte 200 mg cognitive dose in older adults, or a clinician-co-managed cardiometabolic program at the gram-level dose), and a liposomal or piperine-paired form is a reasonable upgrade when reliable plasma exposure matters more than label-milligram cost. The 25 mg "resveratrol blend" inside a multi-ingredient longevity capsule is not in the same conversation. It is below the dose any published trial has tested.
Before you buy any of this, accept the limits of the dataset. The dramatic SIRT1 activation seen in cell and rodent models has not translated cleanly to human clinical endpoints at consumer doses, and the most consistent positive readouts in humans have been at the modest cognitive dose in older adults and the gram-level metabolic dose in adults with established type 2 diabetes. Stilbene supplementation is one of three or four levers worth pulling for healthy-aging goals. It is not the whole answer, and it does not replace the sleep, the resistance training, and the cardiometabolic basics that do the heavy lifting.
Next steps
- Read how we review supplements to see what testing standards we use to vet brands.
- Read the existing roundup on the best supplements for longevity in 2026 for the broader picture on where resveratrol and pterostilbene fit alongside NMN, NR, omega-3, and the rest of the realistic-evidence longevity stack.
- See more from Jonathan Reynolds, ND for the rest of the botanical and naturopathic protocol coverage.
This article is for informational purposes and not medical advice. Resveratrol and pterostilbene supplements can interact with prescription medications including warfarin and other anticoagulants, cyclosporine, several statins, and tamoxifen and other hormone-modulating oncology drugs. Consult a licensed physician before starting any supplement, particularly if you are pregnant, nursing, taking prescription medications, or managing diabetes, cardiovascular disease, a hormone-sensitive cancer history, or another chronic condition.
Reviewed by Jonathan Reynolds, ND, focused on botanical and naturopathic protocols.
Recommended Products
As an Amazon Associate, UsefulVitamins.com earns from qualifying purchases at no extra cost to you. We only recommend products supported by published research or third-party testing.
